CAS 1613458-70-0

GSK-2793660

CAS : 1613458-70-0

GSK-2793660 is a potent and selective analog of a human protein kinase inhibitor that has been shown to induce apoptosis in cancer cells. It is a medicinal compound that inhibits the activity of kinases, which are enzymes involved in cell signaling pathways. GSK-2793660 has demonstrated anticancer activity in preclinical studies, particularly against Chinese hamster ovary (CHO) tumor models. This inhibitor has also been found in urine samples from cancer patients, indicating its potential as a diagnostic tool for cancer. Its ability to selectively target specific kinases makes it a promising candidate for the development of new cancer therapies.

Formule : C₂₀H₂₇N₃O₃

Degré de pureté : Min. 95%

Masse moléculaire : 357.4 g/mol

Ref: 3D-NPC45870

GSK-2793660

CAS : 1613458-70-0

GSK-2793660, an oral, irreversible CTSC inhibitor, aids bronchiectasis research.

Formule : C₂₀H₂₇N₃O₃

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 357.45

Ref: TM-T11466